Supplied byVital Edge Science
Supplier locationAustralia & New Zealand
Dispatch1–3 business days
VerificationReport available
Public report information
Review the testing reference and connected report information before viewing the supplier listing.
Research product overview
Product details supplied through the connected marketplace listing.
<p> Retatrutide is a next-generation peptide engineered to target three major metabolic receptors — GIP, GLP-1, and glucagon — supporting advanced metabolic and body composition research. </p> <p> Public clinical investigations have demonstrated significant weight reduction potential, with trial participants reaching up to 17.5% body weight reduction within 24 weeks under controlled study conditions. </p> <p> Retatrutide research is commonly associated with appetite regulation, metabolic optimisation, insulin sensitivity pathways, and sustained fat metabolism analysis. </p> <p> This Vital Edge Science research batch features ultra-pure Retatrutide with 99.3%+ Janoshik-verified purity, supported by public batch verification and Australia/New Zealand fulfilment. </p> <p> Recommended for reconstitution using bacteriostatic water within a pH range of 5.7 to 7.0. </p> <p> Each vial contains 10mg~30mg of research-grade Retatrutide depending on selected variant. </p> <p> <strong>For research use only.</strong> </p>
This listing is provided for laboratory and research sourcing review. It is not intended for human consumption, medical use or self-administration.